Key facts
- Oryl Photonics’s last known valuation is $3.5M (Jan 2024).
- It has raised $970K; the latest was Later Stage VC in Sep 2025.
- Notable investors include Ecole Polytechnique Federale de Lausanne, S2S Ventures, GENILEM, AIT Startups, Cadfem Germany.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Oryl Photonics
- ·The full record, as it builds
Funding rounds
No funding rounds for Oryl Photonics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oryl Photonics
Developer of solubility measurement technology designed to offer testing while preserving valuable substances. The company offers solubility measurement as a service based on the new solvent redistribution method, enabling clients to make informed decisions and accelerate product development.
- Sector
- Healthcare
- HQ
- Lausanne, Switzerland
- Founded
- 2020
- Employees
- 6
- Website
- orylphotonics.com/
- Ownership
- Privately Held (backing)
Oryl Photonics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oryl Photonics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oryl Photonics in its N-PORT filings yet. We sweep new filings monthly.